Abstract
(Anaesthesia. 2019;74:1305–1319) Uterotonics are routinely used after delivery to manage uterine tone. While various guidelines exist for general management during cesarean deliveries, management of uterine tone following vaginal delivery, and treatment of postpartum hemorrhage, no previous international guideline has addressed uterotonic management during and following cesarean section. The use of uterotonics is largely based on tradition and varies in the choice of drug, timing of administration, dose, route, and speed, and maintenance of administration. Both first-line (oxytocin, carbetocin) and second-line uterotonics carry risk for adverse effects such as hypotension, tachycardia, and ST-segment depression. This consensus statement provides 10 recommendations for the use of uterotonic agents during cesarean section.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
